NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $84,780 | +4.6% | 47,000 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $81,028 | +16.2% | 47,000 | 0.0% | 0.00% | +50.0% |
| Q3 2023 | $69,725 | +16.6% | 47,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $59,808 | -45.6% | 47,000 | -42.7% | 0.00% | -50.0% |
| Q1 2023 | $110,003 | +71797.4% | 82,000 | -15.5% | 0.00% | -33.3% |
| Q4 2022 | $153 | -99.8% | 97,000 | +42.6% | 0.01% | +50.0% |
| Q3 2022 | $95,000 | -40.6% | 68,000 | -41.4% | 0.00% | -50.0% |
| Q3 2020 | $160,000 | -17.1% | 116,000 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $193,000 | +175.7% | 116,000 | +110.9% | 0.01% | +150.0% |
| Q1 2020 | $70,000 | -45.7% | 55,000 | -34.5% | 0.00% | -33.3% |
| Q4 2019 | $129,000 | +11.2% | 84,000 | -1.2% | 0.01% | 0.0% |
| Q3 2019 | $116,000 | – | 85,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 17,500,000 | $29,890,000 | 4.31% |
| SSI INVESTMENT MANAGEMENT LLC | 8,987,000 | $15,319,000 | 1.18% |
| CSS LLC/IL | 14,955,000 | $25,561,000 | 1.09% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,983,000 | $6,799,000 | 0.82% |
| Verition Fund Management LLC | 6,425,000 | $10,968,000 | 0.39% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,495,000 | $16,214,000 | 0.33% |
| MACKAY SHIELDS LLC | 21,609,000 | $36,877,000 | 0.28% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,776,000 | $21,819,000 | 0.25% |
| Calamos Advisors LLC | 24,100,000 | $41,405,000 | 0.23% |
| OAKTREE CAPITAL MANAGEMENT LP | 8,895,000 | $15,184,000 | 0.20% |